Notice of Dividend Amount • Mar 11, 2025
Notice of Dividend Amount
Open in ViewerOpens in native device viewer
| Summary Info | 2024 Profit Distribution Proposal of the Board of Directors |
| Update Notification Flag | No |
| Correction Notification Flag | No |
| Postponed Notification Flag | No |
| Decision Date | 11.03.2025 |
| Date of Related General Assembly | 02.04.2025 |
| Type of Cash Dividend Payment | Cash Dividend Will Not Be Paid |
| Currency Unit | TRY |
| Stock Dividend | Will Not Be Paid |
Cash Dividend Payment Amount and Rates
| Share Group Info | Payment | Cash Dividend To Be Paid For Share With Par Value of 1 TL - Gross (TL) | Cash Dividend To Be Paid For Share With Par Value of 1 TL - Gross (%) | Withholding Rate (%) | Cash Dividend To Be Paid For Share With Par Value of 1 TL - Net (TL) | Cash Dividend To Be Paid For Share With Par Value of 1 TL - Net (%) |
| BIOEN, TREBION00012 | 0,0000000 | 0 | 0 | 0,0000000 | 0 |
Amount and Rate of Cash Dividend Stock Dividend Payment
| Share Group Info | Amount of Stock Dividend (TL) | Rate of Stock Dividend (%) |
| BIOEN, TREBION00012 | 0 | 0 |
Additional Explanations
Our Company's consolidated balance sheet for the accounting period 01.01.2024-31.12.2024, prepared in accordance with the Turkish Accounting Standards (TAS) promulgated by the Public Oversight Accounting Standards Authority (‘POA') in accordance with the provisions of the Communiqué on Principles Regarding International Financial Reporting (‘Communiqué') within the framework of the provisions of the Capital Markets Board's Communiqué on Principles Regarding Financial Reporting in Capital Markets Serial II, No. 14.1, and audited by RSM Turkey Arkan Ergin Uluslararası Bağımsız Denetim A. Ş. for the accounting period 01.01.2024-31.12.2024, the profit for the period is TL 98,595,550. In our legal records prepared in accordance with the provisions of the non-consolidated Tax Procedure Law, there is a loss for the period of TL 90,137,659 and a loss for the previous year of TL 1,345,101,850. Since there is a loss for the previous year in our financial statements prepared in accordance with the provisions of the Unconsolidated Tax Procedure Law, it has been unanimously decided to propose to the Ordinary General Assembly not to distribute dividends by adding the profit for the period 2024 to the retained earnings.
In case of a discrepancy between the Turkish and English versions of this public disclosure statement, Turkish version shall prevail.
DIVIDEND DISTRIBUTION TABLE
BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI A.Ş. 01.01.2024/31.12.2024 Period Dividend Payment Table (TL)
| 1.Paid-In / Issued Capital | 500.000.000 |
| 2. Total Legal Reserves (According to Legal Records) | 0 |
| Information on privileges in dividend distribution, if any, in the Articles of Association: | No |
| * | Based on CMB Regulations | Based on Legal Records |
| 3. Current Period Profit | 137.290.736 | -90.137.659 |
| 4. Taxes Payable (-) | -38.695.186 | 0 |
| 5. Net Current Period Profit | 98.595.550 | -90.137.659 |
| 6. Losses in Previous Years (-) | 0 | -1.345.101.850 |
| 7. Primary Legal Reserve (-) | ||
| 8. Net Distributable Current Period Profit | ||
| Dividend Advance Distributed (-) | ||
| Dividend Advance Less Net Distributable Current Period Profit | ||
| 9. Donations Made During The Year ( + ) | 204.500 | 204.500 |
| 10. Donation-Added Net Distributable Current Period Profit on which First Dividend Is Calculated | ||
| 11. First Dividend to Shareholders | ||
| * Cash | ||
| * Stock | ||
| 12. Dividend Distributed to Owners of Privileged Shares | ||
| 13. Other Dividend Distributed | ||
| * To the Employees | ||
| * To the Members of the Board of Directors | ||
| * To Non-Shareholders | ||
| 14. Dividend to Owners of Redeemed Shares | ||
| 15. Second Dividend to Shareholders | ||
| 16. Secondary Legal Reserves | ||
| 17. Statutory Reserves | ||
| 18. Special Reserves | ||
| 19. Extraordinary Reserves | ||
| 20. Other Distributable Resources |
Dividend Rate Table Explanations
-
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.